282 related articles for article (PubMed ID: 28619037)
1. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
[TBL] [Abstract][Full Text] [Related]
2. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
3. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
4. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
Adel Y; Sadeq Y
Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
6. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
8. Role of interferons (IFNs) in the differentiation of T peripheral helper (Tph) cells.
Tanemura S; Seki N; Tsujimoto H; Saito S; Kikuchi J; Sugahara K; Yoshimoto K; Suzuki K; Kaneko Y; Chiba K; Takeuchi T
Int Immunol; 2022 Sep; 34(10):533-544. PubMed ID: 35780437
[TBL] [Abstract][Full Text] [Related]
9. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
[TBL] [Abstract][Full Text] [Related]
10. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
11. T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
Brkic Z; Corneth OB; van Helden-Meeuwsen CG; Dolhain RJ; Maria NI; Paulissen SM; Davelaar N; van Hamburg JP; van Daele PL; Dalm VA; van Hagen PM; Hazes JM; Versnel MA; Lubberts E
Arthritis Res Ther; 2014 Mar; 16(2):R62. PubMed ID: 24598455
[TBL] [Abstract][Full Text] [Related]
12. Type III Interferons in Systemic Lupus Erythematosus: Association Between Interferon λ3, Disease Activity, and Anti-Ro/SSA Antibodies.
Amezcua-Guerra LM; Márquez-Velasco R; Chávez-Rueda AK; Castillo-Martínez D; Massó F; Páez A; Colín-Fuentes J; Bojalil R
J Clin Rheumatol; 2017 Oct; 23(7):368-375. PubMed ID: 28937472
[TBL] [Abstract][Full Text] [Related]
13. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
[TBL] [Abstract][Full Text] [Related]
14. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
15. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.
Guimarães PM; Scavuzzi BM; Stadtlober NP; Franchi Santos LFDR; Lozovoy MAB; Iriyoda TMV; Costa NT; Reiche EMV; Maes M; Dichi I; Simão ANC
Immunol Cell Biol; 2017 Oct; 95(9):824-831. PubMed ID: 28649995
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
[TBL] [Abstract][Full Text] [Related]
17. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
[TBL] [Abstract][Full Text] [Related]
18. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
[TBL] [Abstract][Full Text] [Related]
20. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
